3 Stocks Pulling The Services Sector Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 60 points (0.4%) at 16,517 as of Tuesday, April 1, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,859 issues advancing vs. 1,154 declining with 141 unchanged.

The Services sector currently sits up 0.8% versus the S&P 500, which is up 0.4%. A company within the sector that fell today was Paychex ( PAYX), up 1.1%. Top gainers within the sector include Vipshop Holdings ( VIPS), up 5.9%, Melco Crown Entertainment ( MPEL), up 5.5%, United Continental Holdings ( UAL), up 4.6%, Expedia ( EXPE), up 3.6% and Magna International ( MGA), up 3.1%.

TheStreet would like to highlight 3 stocks pushing the sector lower today:

3. CVS Caremark ( CVS) is one of the companies pushing the Services sector lower today. As of noon trading, CVS Caremark is down $0.43 (-0.6%) to $74.43 on average volume. Thus far, 2.5 million shares of CVS Caremark exchanged hands as compared to its average daily volume of 5.8 million shares. The stock has ranged in price between $74.12-$75.09 after having opened the day at $74.56 as compared to the previous trading day's close of $74.86.

CVS Caremark Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. CVS Caremark has a market cap of $87.8 billion and is part of the retail industry. Shares are up 4.6% year-to-date as of the close of trading on Monday. Currently there are 15 analysts that rate CVS Caremark a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates CVS Caremark as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CVS Caremark Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Walgreen Company ( WAG) is down $0.44 (-0.7%) to $65.58 on average volume. Thus far, 2.7 million shares of Walgreen Company exchanged hands as compared to its average daily volume of 6.9 million shares. The stock has ranged in price between $65.00-$66.18 after having opened the day at $65.61 as compared to the previous trading day's close of $66.03.

Walgreen Co., together with its subsidiaries, operates a network of drugstores in the United States. It provides consumer goods and services, pharmacy, and health and wellness services through drugstores, as well as through mail, and by telephone and online. Walgreen Company has a market cap of $62.4 billion and is part of the retail industry. Shares are up 14.9% year-to-date as of the close of trading on Monday. Currently there are 12 analysts that rate Walgreen Company a buy, 2 analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Walgreen Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, reasonable valuation levels and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Walgreen Company Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Comcast ( CMCSA) is down $0.27 (-0.5%) to $49.77 on average volume. Thus far, 6.9 million shares of Comcast exchanged hands as compared to its average daily volume of 15.9 million shares. The stock has ranged in price between $49.63-$50.38 after having opened the day at $50.34 as compared to the previous trading day's close of $50.04.

Comcast Corporation operates as a media and technology company worldwide. It operates through Cable Communications, Cable Networks, Broadcast Television, Filmed Entertainment, and Theme Parks segments. Comcast has a market cap of $106.0 billion and is part of the media industry. Shares are down 3.7% year-to-date as of the close of trading on Monday. Currently there are 21 analysts that rate Comcast a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Comcast as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, growth in earnings per share, increase in net income and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Comcast Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the services sector could consider iShares Dow Jones US Cons Services ( IYC) while those bearish on the services sector could consider ProShares Ultra Short Consumer Sers ( SCC).
null

If you liked this article you might like

Rite Aid Surges After Albertsons Plans to Buy Part of Drugstore Chain

Rite Aid Surges After Albertsons Plans to Buy Part of Drugstore Chain

Goldman Bankers (Mostly) Upbeat on Tech M&A and IPO Trends

Goldman Bankers (Mostly) Upbeat on Tech M&A and IPO Trends

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

5 Awesome Stock Picks That Will Survive a Choppy Market

5 Awesome Stock Picks That Will Survive a Choppy Market

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff